# Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US

> **NCT04010695** · NA · COMPLETED · sponsor: **PATH** · enrollment: 250 (actual)

## Conditions studied

- G6PD Deficiency

## Interventions

- **DIAGNOSTIC_TEST:** SD Biosensor G6PD Analyzer
- **DIAGNOSTIC_TEST:** Pointe Scientific Test Kit
- **DIAGNOSTIC_TEST:** HemoCue System

## Key facts

- **NCT ID:** NCT04010695
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-13
- **Primary completion:** 2019-09-19
- **Final completion:** 2019-09-19
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2022-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04010695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04010695, "Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04010695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
